SE8406450D0 - 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith - Google Patents

5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith

Info

Publication number
SE8406450D0
SE8406450D0 SE8406450A SE8406450A SE8406450D0 SE 8406450 D0 SE8406450 D0 SE 8406450D0 SE 8406450 A SE8406450 A SE 8406450A SE 8406450 A SE8406450 A SE 8406450A SE 8406450 D0 SE8406450 D0 SE 8406450D0
Authority
SE
Sweden
Prior art keywords
leukemia
pyrimidinecarboxamides
hydrogen
thiocarboxamides
treatment
Prior art date
Application number
SE8406450A
Other languages
English (en)
Other versions
SE8406450L (sv
SE469171B (sv
Inventor
A D Brewer
J A Minatelli
Original Assignee
Uniroyal Inc
Uniroyal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Inc, Uniroyal Ltd filed Critical Uniroyal Inc
Publication of SE8406450D0 publication Critical patent/SE8406450D0/sv
Publication of SE8406450L publication Critical patent/SE8406450L/sv
Publication of SE469171B publication Critical patent/SE469171B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8406450A 1983-12-19 1984-12-18 2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav SE469171B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US66520184A 1984-10-26 1984-10-26
US66526784A 1984-10-26 1984-10-26

Publications (3)

Publication Number Publication Date
SE8406450D0 true SE8406450D0 (sv) 1984-12-18
SE8406450L SE8406450L (sv) 1985-06-20
SE469171B SE469171B (sv) 1993-05-24

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406450A SE469171B (sv) 1983-12-19 1984-12-18 2-tioxo-5-pyrimidinkarboxamider, farmaceutisk komposition innehaallande dessa samt foerfarande foer framstaellning daerav

Country Status (19)

Country Link
US (1) US4634707A (sv)
JP (1) JPH0660164B2 (sv)
AT (1) AT394194B (sv)
AU (1) AU580746B2 (sv)
BE (1) BE901301A (sv)
CH (1) CH671225A5 (sv)
DE (1) DE3446371A1 (sv)
DK (1) DK164055C (sv)
ES (1) ES8606296A1 (sv)
FR (1) FR2557108B1 (sv)
GB (1) GB2152047B (sv)
GR (1) GR82494B (sv)
IE (1) IE57675B1 (sv)
IL (1) IL73840A (sv)
IT (1) IT1213257B (sv)
LU (1) LU85696A1 (sv)
NL (1) NL8403856A (sv)
NZ (2) NZ210599A (sv)
SE (1) SE469171B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
PH24423A (en) * 1985-02-15 1990-06-25 Ciba Geigy Ag 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
WO1991013623A1 (en) * 1990-03-09 1991-09-19 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
AU2001257230B2 (en) 2000-04-24 2006-09-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
EP3247704A4 (en) * 2015-01-22 2018-10-03 Acquist LLC Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) * 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
WO2018009615A1 (en) 2016-07-06 2018-01-11 Acquist Llc Compounds and their use for reducing uric acid levels
IT201700028709A1 (it) * 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
DE2962834D1 (en) * 1978-10-30 1982-07-01 Fujisawa Pharmaceutical Co 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
ZA849819B (en) * 1983-12-19 1985-07-31 Uniroyal Inc 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
JPS641445A (en) 1987-06-22 1989-01-05 Toshiba Corp Manufacture of stator coil

Also Published As

Publication number Publication date
IL73840A0 (en) 1985-03-31
BE901301A (fr) 1985-06-18
IE843237L (en) 1985-06-19
DK609184A (da) 1985-06-20
GB2152047B (en) 1988-04-27
JPS62174058A (ja) 1987-07-30
DK609184D0 (da) 1984-12-18
SE8406450L (sv) 1985-06-20
GB2152047A (en) 1985-07-31
IT8424104A0 (it) 1984-12-18
DK164055B (da) 1992-05-04
GB8432112D0 (en) 1985-01-30
ATA402684A (de) 1991-08-15
FR2557108A1 (fr) 1985-06-28
DE3446371A1 (de) 1985-06-27
IT1213257B (it) 1989-12-14
LU85696A1 (fr) 1985-09-12
JPH0660164B2 (ja) 1994-08-10
CH671225A5 (sv) 1989-08-15
AU3690884A (en) 1985-07-04
NL8403856A (nl) 1985-07-16
US4634707A (en) 1987-01-06
IE57675B1 (en) 1993-02-24
SE469171B (sv) 1993-05-24
DE3446371C2 (sv) 1990-08-16
GR82494B (en) 1985-04-19
IL73840A (en) 1988-11-15
AT394194B (de) 1992-02-10
ES8606296A1 (es) 1986-04-16
ES538829A0 (es) 1986-04-16
FR2557108B1 (fr) 1988-11-18
AU580746B2 (en) 1989-02-02
NZ220399A (en) 1987-09-30
DK164055C (da) 1992-09-28
NZ210599A (en) 1987-09-30

Similar Documents

Publication Publication Date Title
SE8406450D0 (sv) 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
FI915010A0 (fi) Nya aryl- och heteroaryletenylenderivat och foerfarande foer framstaellning av desamma.
AU5216586A (en) Arylaminoalkyl- and aryloxyalkyl guanidines
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
AU630777B2 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapeutics
GB2108964B (en) 1-b-d-arabinofuranosyl-(e)-5-(2-halogenovinyl)uracil-5'-phosphates
FI863836A (fi) Kinolinderivat.
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
AU3484389A (en) 6-phenyl-3(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives, their preparation and their application in therapy
DK288686A (da) Farmaceutiske praeparater
CY1679A (en) Stabilization of antibiotic compositions with salts
SE8601826D0 (sv) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
YU44872B (en) Process for obtaining an debroming compound
ES8506304A1 (es) Proceso de produccion de los derivados de la piperacina
AU562182B2 (en) Bicyclo(4,2,0)1,3,5-octatriene derivatives
GB2005247A (en) Perhydro naphthalene derivatives
DE3464602D1 (en) 4-alkylimidazole derivatives, their preparation and their application
SE8800863L (sv) 3-(2-haloalkyl)-1,4-oxatiiner och 2-(2-haloalkyl)1,4-ditiiner och bahandling av leukemi och tumoerer daermed
HUT47256A (en) Process for producing aralkyl-4h-1,2,4-triazole derivatives
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
GR82015B (sv)
EA199800677A1 (ru) Способ ингибирования опухоли толстой кишки
KR920008062A (ko) 신규 안트라사이클린 클리코사이드 유도체 및 그 제조방법
TH2435EX (th) สาร 2-(2-ซับสติทิว เบนโซอิล)-1-,3-ไซโคลเฮกเซนไดโอน

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8406450-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8406450-0

Format of ref document f/p: F